Video Latest - ecancer

Mechanisms of immune escape in non-Hodgkin lymphoma

Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA

4 May 2016

'Helper' T Cells effective in therapy, and shows early clinical responses in patients with metastatic cancer

Dr Yong-Chen William Lu - National Cancer Institute, Bethesda, USA

4 May 2016

Innovations in assessing patient outcomes

Dr Heather Jim - Moffitt Cancer Center, Tampa, USA

3 May 2016

Repopulation of cancer stem cells in therapeutic resistance

Prof Keith Chan - Baylor College of Medicine, Houston, USA

3 May 2016

Technologies for personalised cancer immunotherapies

Prof James Heath - California Institute of Technology, Pasadena, USA

3 May 2016

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors

Dr Shivaani Kummar - Stanford University, Stanford, USA

3 May 2016

Comment on RESONATE2 and CLL115 trials

Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK

29 Apr 2016

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA

29 Apr 2016

Current trials in chronic lymphocytic leukaemia

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

29 Apr 2016

Microenvironment of chronic lymphocytic leukaemia

Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

29 Apr 2016

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia

29 Apr 2016

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL

Prof Jan Burger, MD Anderson Cancer Center, Texas, USA

29 Apr 2016

Video